000 02385 a2200637 4500
005 20250518080106.0
264 0 _c20200803
008 202008s 0 0 eng d
022 _a1879-0852
024 7 _a10.1016/j.ejca.2019.11.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAscierto, Paolo A
245 0 0 _aUpdate on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c02 2020
300 _a33-44 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBenzimidazoles
_xadministration & dosage
650 0 4 _aCarbamates
_xadministration & dosage
650 0 4 _aDiarrhea
_xchemically induced
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aNausea
_xchemically induced
650 0 4 _aOutcome Assessment, Health Care
_xmethods
650 0 4 _aPrognosis
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aSulfonamides
_xadministration & dosage
650 0 4 _aVemurafenib
_xadministration & dosage
650 0 4 _aVomiting
_xchemically induced
700 1 _aDummer, Reinhard
700 1 _aGogas, Helen J
700 1 _aFlaherty, Keith T
700 1 _aArance, Ana
700 1 _aMandala, Mario
700 1 _aLiszkay, Gabriella
700 1 _aGarbe, Claus
700 1 _aSchadendorf, Dirk
700 1 _aKrajsova, Ivana
700 1 _aGutzmer, Ralf
700 1 _ade Groot, Jan Willem B
700 1 _aLoquai, Carmen
700 1 _aGollerkeri, Ashwin
700 1 _aPickard, Michael D
700 1 _aRobert, Caroline
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 126
_gp. 33-44
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2019.11.016
_zAvailable from publisher's website
999 _c30483654
_d30483654